TY - JOUR T1 - Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal JO - PharmacoEconomics UR - http://eprints.whiterose.ac.uk/93179/ PY - 2015/12/21 AU - Pandor A AU - Pollard D AU - Chico T AU - Henderson R AU - Stevenson M ED - DO - DOI: 10.1007/s40273-015-0351-2 PB - Springer Science and Business Media LLC VL - 34 IS - 5 SP - 463 EP - 477 Y2 - 2025/08/15 ER -